Fig. 1From: Radiomics combined with clinical characteristics predicted the progression-free survival time in first-line targeted therapy for advanced non-small cell lung cancer with EGFR mutationA Time-dependent ROC curves of the “gini-index-Logistic regression” model of using the top-10 features at 10 months. B Kaplan Meier survival curves of EGFR positive NSCLC patients. The p-values were calculated using the log-rank testsBack to article page